Application of dexmedetomidine nasal drip combined with sevoflurane inhalation in lacrimal duct exploration in pediatric outpatient department

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200059121

Enrollment

Unknown

Registered

2022-04-25

Start date

2022-04-25

Completion date

Unknown

Last updated

2024-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative agitation

Interventions

Group S:Dexmedetomidine nasal drops combined with sevoflurane inhalation induction

Group M:Sevoflurane inhalation induction

Eligibility

Sex/Gender

All

Age

0.5 Years to 1 Years

Inclusion criteria

Inclusion criteria: 1. Single tear tunnel probing; 2. ASA grade I-II, aged 6-12 months, BMI 20-26kg/m^2; 3. Preoperative routine examination and blood routine were normal.

Exclusion criteria

Exclusion criteria: 1. Premature infants, children with cognitive impairment, abnormal cardiopulmonary function, developmental delay and mental retardation; 2. Recent diseases such as severe upper respiratory tract infection; 3. History of anesthesia operation; 4. Children with cardiovascular diseases before surgery.

Design outcomes

Primary

Measure	Time frame
Agitation;Recovery time;	—

Countries

China

Contacts

Public ContactJiang Wanna

The Eye Hospital of Wenzhou Medical University

jiangwanna1314@sina.com+86 13758475106

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026